Fri, November 17, 2023

Raghuram Selvaraju Reiterated (ADMA) at Strong Buy and Held Target at $5 on, Nov 17th, 2023

Raghuram Selvaraju of HC Wainwright & Co., Reiterated "ADMA Biologics, Inc." (ADMA) at Strong Buy and Held Target at $5 on, Nov 17th, 2023.

Raghuram has made no other calls on ADMA in the last 4 months.



There are 2 other peers that have a rating on ADMA. Out of the 2 peers that are also analyzing ADMA, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Elliot Wilbur of "Raymond James" Maintained at Strong Buy with Increased Target to $6 on, Thursday, August 10th, 2023
  • Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $6 on, Thursday, August 10th, 2023